CapitalBio
Fluidigm of South San Francisco, Calif., has received US Patent No.
CapitalBio and Tsinghua University of Beijing have received US Patent No.
CapitalBio, Ahead of Lab Expansion, Debuts Chromosomal Microarray Analysis Services in China
Premium
The global adoption of microarrays for the detection of genetic abnormalities has continued into the new year, with Chinese life sciences company CapitalBio announcing recently the introduction of chromosomal microarray analysis services via its medical testing laboratories.
China's CapitalBio on Track to Open New Consumer, Clinical Genetics Testing Facility
NEW YORK (GenomeWeb News) – Chinese life science company CapitalBio will solidify its efforts to become a major laboratory testing player in the country's clinical and consumer genetics markets by opening a new facility next year.
By law, Chinese samples cannot leave China. That fact has made Shanghai Biochip a partner for international pharmaceutical companies seeking to conduct various trials in the country.
Feb 21, 2012
Apr 19, 2011
IP Roundup, Apr 19, 2011
Premium
Nov 16, 2010
Nov 11, 2010
Roche to Team with CapitalBio on MDx Applications
Oct 12, 2010
IP Roundup: Oct 12, 2010
Premium
Aug 17, 2010
IP Roundup: Aug 17, 2010
Premium
Aug 3, 2010
IP Roundup: Aug 3, 2010
Premium
May 18, 2010
IP Roundup: May 18, 2010
Premium
May 13, 2010
CapitalBio TB Tests Cleared in China
Apr 27, 2010
IP Roundup: Apr 27, 2010
Premium
Feb 16, 2010
Feb 11, 2010
CapitalBio Becomes Roche NimbleGen Service Provider
Nov 10, 2009
IP Roundup, Nov 10, 2019
Premium
Sep 1, 2009
IP Roundup: Sep 1, 2009
Premium
Aug 6, 2009
New Products: Aug 6, 2009
Premium
Jun 16, 2009